SOMAVERT (pegvisomant for injecion)
Understanding AcromegalyControlling IGF-1About SomavertFor Patients on SOMAVERTPfizer Bridge ProgramFAQs

What is SOMAVERT?

SOMAVERT® (pegvisomant for injection) is a medicine used to treat acromegaly. SOMAVERT decreases the action of growth hormone (GH) and levels of IGF-I (Insulin-like Growth Factors) circulating in the blood. This helps to control acromegaly.

SOMAVERT is indicated for the treatment of acromegaly in patients who have had an inadequate response to surgery and/or radiation therapy and/or other medical therapies, or for whom these therapies are not appropriate. The goal of treatment is to normalize serum IGF-I levels.

It helps stop your body from making too much IGF-I, which can help with some of your symptoms.

Has SOMAVERT been shown to be effective?

In an important clinical trial, groups of patients treated with SOMAVERT had a decrease in IGF-I levels compared with placebo. More patients receiving SOMAVERT achieved normalized IGF-I levels compared with placebo. SOMAVERT also improved total score for the 5 signs and symptoms in all patient groups compared with placebo. The signs and symptoms are soft tissue swelling, joint pain, headaches, sweating, and fatigue.

How will I know if my IGF-I levels are controlled?

Your doctor will monitor your IGF-I levels regularly. Based on your IGF-I levels, your doctor may change your dose of SOMAVERT to get better control and help normalize IGF-I levels.

Please see Full Prescribing Information.